“If I feel well today, why do I still need this medicine?” For many people with FMF, the answer is prevention. The treatment plan is meant to help during the quiet days as well as the difficult ones.
What is the goal?
Colchicine is a foundation of long-term FMF care. Treatment aims to prevent attacks and control ongoing inflammation, including inflammation between episodes. Preventing AA amyloidosis—a complication that can affect the kidneys—is another important goal. Your clinician follows symptoms and appropriate tests together.
Colchicine is also used in other conditions, but the purpose and instructions can differ. Do not copy a gout treatment schedule or another person’s prescription into an FMF plan. See the FMF overview.
Take the actual prescription seriously
Use the prescribed product and schedule. Tablets, capsules and liquids may have different instructions. If a dose is missed, ask your pharmacist or follow the instructions supplied with your prescription; do not take extra doses to improvise a catch-up plan.
Give every prescriber and pharmacist your full medication and supplement list. Kidney or liver problems and certain drug interactions can increase toxicity. Some antibiotics and other medicines can interact dangerously. Check before adding a new medicine, including a short course from another clinic. Discuss grapefruit with your pharmacist.
Side effects deserve a conversation
Diarrhea, nausea or abdominal discomfort can make a daily medicine hard to take. Tell the team rather than quietly abandoning treatment. The dose or plan may need review. New muscle weakness, unusual bruising, severe symptoms or a suspected overdose needs prompt medical advice; an overdose can be serious even before someone looks very ill.
The medicine information sheet and the label for your particular product provide more complete safety information.
If attacks continue
Continuing symptoms do not automatically mean the medicine has failed. Review missed doses, tolerability, access, interactions and whether the symptoms have another explanation. Some patients need additional treatment, including IL-1-targeted medicines. That decision belongs with the care team.
Adherence can be difficult for practical reasons: refills, cost, routines or side effects. Explain which obstacle is getting in the way. The most useful plan is one you can actually follow.
Bring these questions
- What is this medicine meant to prevent in my case?
- How will we assess benefit and monitor safety?
- What should I do about missed doses or side effects?
- Who checks interactions when another clinician prescribes something?
- What is the next step if symptoms or inflammation persist?
Use the treatment and monitoring pages of the patient workbook. Discuss pregnancy planning, breastfeeding or changes in health early; do not stop treatment based on a general webpage.
Sources and further reading
- EULAR/PReS FMF recommendations: 2024 update, published 2025
- MedlinePlus: colchicine medicine information
- DailyMed: colchicine prescribing information
General education, not a diagnosis or an individual treatment plan. Use these resources with your own care team. How this website is edited.